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OBJECTIVE — Proinﬂammatory advanced glycation end products (AGEs) found in ther-
mally processed foods correlate with serum AGEs (sAGEs) and promote type 1 and type 2
diabetes in mice. Herein we assess the relationship of maternal blood and food AGEs to circu-
lating glycoxidants, inﬂammatory markers, and insulin levels in infants up to age 1 year.
RESEARCH DESIGN AND METHODS — AGEs (N
ε -carboxymethyllysine [CML] and
methylglyoxalderivatives)weretestedinseraofhealthymothersinlabor(n60),theirinfants,
and infant foods. Plasma 8-isoprostane, fasting glucose, insulin, leptin, and adiponectin levels
were assessed in 12-month-old infants.
RESULTS — Signiﬁcant correlations were found between newborn and maternal serum CML
(sCML)(r0.734,P0.001)serummethylglyoxalderivatives(sMGs)(r0.593,P0.001),
and 8-isoprostanes (r  0.644, P  0.001). Infant adiponectin at 12 months negatively corre-
lated with maternal sCML (r  0.467, P  0.011), whereas high maternal sMGs predicted
higher infant insulin or homeostasis model assessment (P  0.027). Infant sAGEs signiﬁcantly
increased with the initiation of processed infant food intake, raising daily AGE consumption by
7.5-fold in year 1.
CONCLUSIONS — Maternal blood and food-derived AGEs prematurely raise AGEs in chil-
dren to adult norms, preconditioning them to abnormally high oxidant stress and inﬂammation
and thus possibly to early onset of disease, such as diabetes.
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D
iabetes is a major chronic inﬂam-
matory disease, the incidence of
which is currently exploding across
the world. Especially disturbing has been
therisingincidenceofchildhooddiabetes
(1,2). The current pathogenesis of both
diabetes type 1 and type 2 includes a
strong inﬂammatory component and is
characterized by an earlier onset than be-
fore and an escalating incidence (3).
The causes of the underlying inﬂam-
mation and oxidant stress are still being
debated. Beyond genetic considerations,
maternal transmission of disease risk has
recently been raised as a serious contrib-
uting factor to diabetes, which increas-
ingly affects younger adults and children
(2). Children of obese, of diabetic, and of
pre-diabetic mothers are more suscepti-
ble to diabetes, pointing to maternal
transmission of pro-diabetic risk factor(s)
(1,2). Changes in the modern diet have
been implicated in both type 1 and type 2
diabetes (4).
Among the recently proposed exoge-
nous factors that might predispose indi-
viduals to an abnormal increase in
oxidant stress and inﬂammation are diet-
derived pro-oxidant advanced glycation
end products (AGEs) (5). These com-
pounds have been shown to be orally ab-
sorbed and/or to increase circulating
AGEs in the absence of diabetes (6). AGE
compounds common in vivo and in
foods, such as N
ε -carboxymethyllysine
(CML) and methylglyoxal derivatives,
have been shown to promote type 1 dia-
betesinNODmice,viaearlyautoimmune
cytotoxic T-cell activation (7), as well as
type 2 diabetes in db/db
/ mice (8),
high-fat–fed (9), or aging C57BL6 mice
(10) via increased oxidant stress and in-
ﬂammation. Moreover, lowering the con-
centration of AGEs in food prevented
diabetes in these animal models (7–10).
Clinical studies in healthy and diabetic
subjects have supported the view that
AGEs inherent in thermally processed
westernized foods predispose individuals
to increased oxidant stress and inﬂamma-
tion, independent of caloric or nutrient
consumption and that an AGE-restricted
diet can improve their inﬂammation and
oxidant stress (11,12).
Because serum AGEs (sAGEs) can be
elevated in healthy individuals consum-
ing AGE-rich foods (13), were this to oc-
cur in pregnancy, an excess of maternal
oxidants could adversely inﬂuence fetal
development, infancy, or adult health, as
previously shown for high glucose (2),
cigarette smoke, or alcohol (14,15). Spe-
ciﬁc to diabetes, AGEs can impair insulin
production (16) or function (17). The
contribution of maternal and/or of food-
derived AGEs to the circulating AGEs of
newborn and infant children or their
implications, however, has not been
addressed.
The clinical study presented herein
addresses the following relationships: 1)
maternaltoinfantsAGEsandoxidants,2)
infant sAGEs and select metabolic and in-
ﬂammatory markers, and 3) food AGEs
and infant sAGEs during the 1st year of
life. We report that at birth infant sAGEs
closely correlate with maternal AGEs and
later with food AGEs. High AGE levels in
mothers predict lower adiponectin and
higher plasma insulin levels or homeosta-
sis model assessment (HOMA). We pos-
tulate that prematurely elevated infant
glycoxidant burden from maternal and
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creased incidence of diabetes in the
young.
RESEARCH DESIGN AND
METHODS— This observational
study was approved by the institutional
review board at the University of Chile
School of Medicine, Santiago, Chile. All
participating mothers provided informed
consent.Allwomenwereadmittedforde-
livery at the Hospital San Borja Arriaran,
Santiago, Chile, during the period be-
tween May and September 2006. Exclu-
sioncriteriaincludedanychronicdisease,
chronic use of medications, abnormal
pregnancy,orinabilitytoattendtheclinic
visits at 6 and 12 months postpartum. All
women had normal fasting glucose
(100 mg/dl) and a normal oral glucose
tolerance test (oral intake of 75 g of glu-
cose)with2-hbloodglucose140mg/dl
during pregnancy.
Fasting blood samples were obtained
from all mothers and from the umbilical
cord of all newborns at the time of deliv-
ery. A full clinical assessment of each
newborn was performed including
weight, height, and circumference of
head, abdomen (at the level of the umbi-
licus), and hip. During two follow-up vis-
its, at 6 and 12 months, a full clinical and
anthropometric assessment was per-
formed, which included questions about
feeding patterns or intercurrent illness,
and a sample of blood was obtained.
Blood samples were centrifuged, and
aliquots of plasma or serum were used for
glucose and insulin measurements by the
hospital clinical laboratory or frozen (at
80°C) until assessed by the Laboratory
of Experimental Diabetes and Aging, The
Mount Sinai School of Medicine (New
York, NY). Serum samples were tested for
CML (4G9 monoclonal antibody; Alteon,
Northvale, NJ) and for methylglyoxal de-
rivatives, such as MG-H1 (MG3D11
monoclonal antibody) by enzyme-linked
immunosorbent assays (ELISAs), based
on standards characterized by high-
performance liquid chromatography and
gas-liquid chromatography-mass spec-
trometry,asdescribed(18).Plasma8-iso-
prostane, adiponectin, leptin, and insulin
levels were measured using commercially
available ELISA kits. Insulin resistance
was calculated according to the HOMA
index as fasting insulin  fasting glucose
(millimoles per liter)/22.5 (13).
All newborns were provided with
powdered fortiﬁed cow milk (whole bo-
vine milk homogenized and enriched
with vitamin C, iron, zinc, and copper)
(Purita fortiﬁcada; CALO [Central de
Abastecimiento del Ministerio de Salud
de Chile], Osorno, Chile) according to
Chilean government policy, which ap-
plies until a child reaches 6 years of age.
Statistical analysis
DataarepresentedasmeansSD,except
in ﬁgures, where they are presented as
mean  SEM. Differences of mean values
between groups were tested by an un-
pairedStudentttestorANOVA(followed
by a Bonferroni correction for multiple
comparisons), depending on the number
ofgroups.Correlationanalyseswereeval-
uated by Pearson correlation coefﬁcient.
Signiﬁcant differences were deﬁned as
P  0.05 and are based on two-sided
tests. Data were analyzed using the SPSS
statistical program (SPSS 16.0 for Win-
dows; SPSS, Chicago, IL).
RESULTS
General results
All women admitted in labor (n  60)
were apparently healthy, with an aver-
age  SD age of 23  6 years. The BMI
was23.9kg/m
2atthebeginningand29.9
kg/m
2 at the end of pregnancy, and aver-
age weight gain during pregnancy was
15  6 kg. The infants were all born by
vaginal delivery and had an average ges-
tational age of 39  0.8 weeks (range
38–41 weeks), and their APGAR score at
1 and 5 min was 8. Anthropometric pa-
rameters of infants during their 1st year
are described in Table 1.
Maternal-infant relationship of
circulating AGEs and 8-isoprostanes
Average levels of maternal sAGEs, serum
CML (sCML) (4.9  3 units/ml), and se-
rum methylglyoxal derivatives (sMGs)
(1.09  0.60 nmol/ml) at labor were
within the normal range. There were sig-
niﬁcant intraindividual correlations be-
tween levels of sCML and corresponding
levels of sMG (r  0.634, P  0.001) and
8-isoprostane (r  0.744, P  0.001).
Maternal sAGEs were not correlated with
BMI or biochemical parameters.
Maternal sCML levels correlated with
newborn sCML levels (r  0.734, P 
0.001) (Fig. 1A), maternal sMG with in-
fant sMG levels (r  0.593, P  0.001)
(Fig. 1B), and maternal 8-isoprostanes
withthoseoftheirinfants(r0.644,P
0.001) (Fig. 1D), but these correlations
were no longer evident by 12 months of
age (data not shown). In addition, infant
sCML levels correlated with the corre-
sponding infant sMG levels (r  0.525,
P0.001)(Fig.1C).sCMLlevelsatbirth
also correlated with the respective sCML
at 6 months of age (r  0.648, P 
0.001), although not with sMGs. These
ﬁndings suggested maternal transmission
of sAGEs to the newborn child.
Circulating AGEs in infants increase
markedly within the 1st year
Infant sCML levels at birth were on aver-
age 50% less than the maternal sCML
levels, but increased progressively with
time in the absence of hyperglycemia, ev-
ident stress (i.e., infection), or other ad-
verse events (Fig. 2A). At 12 months,
infant sCML levels were nearly twofold
above those at birth and were similar to
maternal or adult values. sMG levels in
the infants, although similar at birth to
maternal levels, signiﬁcantly exceeded
maternal sMGs by 12 months (Fig. 2B).
Both sCML and sMGs retained a positive
correlation with 8-isoprostanes from
birththroughoutthe1styearoflife(r 
0.744, P  0.001 for sCML and r 
0.575, P  0.001 for sMGs at birth;
r  0.822, P  0.001 for sCML and r 
0.390, P  0.021 for sMGs at 6 months;
Table 1—Anthropometric characteristics of children during the study
Newborn 6 months 12 months
Weight (g) 3,477  375 8,264  962 10,252  955
Height (cm) 50  36 7  27 6  2
Heart rate (bpm) 147  12 128  13 128  13
Mean arterial pressure (mmHg) NA 66.8  8.9 72.8  11.3
Head circumference (cm) 34.6  1.2 43.5  1.7 46.3  1.2
Chest circumference (cm) NA 44.9  2.2 47.3  1.7
Abdominal circumference (cm) 30  1.6 42.9  34 4  2
Hip circumference (cm) 28  1.4 41  34 3  2
Data are means  SD. As expected, the difference of all these parameters over time is statistically signiﬁcant
(ANOVA). NA, not available.
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r  0.400, P  0.031 for sMGs at 12
months).
No relationship was observed be-
tween infant sCML or sMG levels and an-
thropometric parameters. No sex-based
differences were observed in any clinical
and biochemical parameters at any age,
except for body weight at 6 months (boys
8,576  970 vs. girls 7,887  834, P 
0.034) and at 12 months (boys 10,526 
1,113 vs. girls 9,830  490, P  0.030).
Plasma insulin and adiponectin
levels in infants correlate with
maternal AGEs
Insulin, leptin, and adiponectin levels
weretestedasindicatorsofoxidantstress.
Infant plasma insulin and glucose (or
HOMA) levels were within the normal
range at birth and remained stable during
the 1st year of life (insulin 5.4  9, 3.2 
1.6, and 4.0  3 units/ml; glucose 82 
22, 85  10, and 84  8 mg/dl; and
HOMA 1.12  2.1, 0.69  0.4, and
0.83  0.6 at birth, 6 months, and 12
months, respectively). However, 12-
month-old infants born to mothers in the
upper quartile for sMGs had insulin and
HOMA levels signiﬁcantly higher than
those of infants born to mothers in the
lowest sMG quartile (Fig. 2C). A similar
trend was observed after analysis on the
basis of maternal sCML extreme quartiles
(NS).
A negative association was observed
between maternal sCML and infant adi-
ponectin (Fig. 2D), although values of
plasma adiponectin were higher than
those in mothers (26  7 vs. 14.5  6
	g/ml; P  0.001). Negative correlations
were also found between infant plasma
adiponectin and the respective sCML
(r  0.527, P  0.003), sMG (r 
0.404, P  0.030), and 8-isoprostane
(r  0.474, P  0.09) levels at 12
months, whereas leptin levels showed no
distinct patterns (data not shown), except
forlowervaluesininfantsthaninmothers
(6.4  2 vs. 20  1 ng/ml; P  0.001).
Infant circulating AGE levels
correlate with food AGE intake
The AGE content of several common in-
fantfoodswastestedtodeterminethepo-
tential contribution of external AGEs
from food to circulating AGEs in infants.
The levels of AGEs in human and bovine
milk were quite similar (Table 2). How-
ever,comparedwithmilk,measuredAGE
Figure 1—Association between circulating AGE and 8-isoprostane levels in mothers and new-
borns. Correlations between maternal and newborn sCML (A), maternal and newborn sMGs (B),
sCML and sMGs at birth (C), and maternal and newborn 8-isoprostane (8-iso) (D). Correlations
were estimated by Pearson correlation coefﬁcients.
Figure 2—A and B: Circulating levels of AGEs in infants increase with age. Serum levels of CML
(A) and methylglyoxal derivatives (B) were measured by ELISAs in maternal (M) and umbilical
cord blood from newborns at delivery (0) and children at age 6 and 12 months. Data shown are
means  SEM. Statistically signiﬁcant differences are shown between mother and infants at any
age (*), between newborn and 6 months (#), newborn and 12 months (§), and 6 and 12 months
(&). C and D: At 12 months of age, lower adiponectin levels (D) and higher HOMA levels (C)i n
infants correlate with higher maternal sAGE levels. HOMA levels were analyzed at 12 months
afterseparationofinfantsingroupsbyextremequartilesofmaternalsMGs.*P0.05.D:Plasma
adiponectin levels in 12-month-old infants were correlated (Pearson correlation coefﬁcient) with
maternal sCML levels. Data are means  SEM.
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as Enfamil, were nearly 100-fold higher
(Table 2) and estimates of AGE levels in
common infant foods indicated a signiﬁ-
cant increase in AGE content (Table 2),
associated with higher AGE delivery to
the infants, compared with that of milk
alone. Namely, for the ﬁrst 6 months the
infant diet consisted mostly of maternal
breast milk (AGE intake 15 kU/kg/day,
based on 1,000 ml of breast milk/day).
Thisfeedingmodewasgraduallyreplaced
by nonmaternal milk and by infant non-
milk food. At age 6 months, all infants
were receiving one solid food per day and
additional feedings of maternal and non-
maternal milk (by bottle) (AGE intake
76 kU/kg/day). By age 12 months, 90%
of the infants were receiving on average
two solid meals per day in addition to
milk (AGE intake 111 kU/kg/day) (Ta-
ble 2). Therefore, by 6 months the infant
daily AGE consumption had increased by
ﬁvefold and by 12 months it had in-
creased by 7.5-fold relative to that in
the ﬁrst 3–6 months.
CONCLUSIONS — These studies
demonstrate the appearance of proin-
ﬂammatory AGEs at adult levels in the
neonate circulation, ﬁrst in a direct rela-
tionship to maternal blood AGE levels
and later to AGEs derived from thermally
processedinfantfoods.Infantsofmothers
with elevated sAGEs had higher plasma
insulin and HOMA and lower adiponec-
tin levels than infants born to mothers
with low AGE levels. Because AGEs are
inﬂammatory, an excess of AGEs trans-
ferred via the placenta or fed to infants
could potentially initiate changes pro-
motingdisease,namelydiabetes,atalater
time. These hypothesis-generating clini-
cal ﬁndings are supported by previous
ﬁndings in mice (7) and warrant further
inquiry.
The close relationships of circulating
AGEs in both mothers and infants and
their pro-oxidant potential were sup-
ported by highly signiﬁcant correlations
foundintwosAGEs(sCMLandsMG)and
a marker of oxidant stress (8-isopros-
tane). Circulating AGE levels in healthy
mothers were likely to reﬂect AGEs con-
sumed with their diet (13), as pregnancy
has no apparent effect on maternal sAGE
levels (19). Maternal AGEs could be
transferredfromthemothertothefetusor
inﬂuence the generation of fetal AGEs.
The highly signiﬁcant correlation be-
tween maternal and infant sAGEs before
the introduction of exogenous foods to
the infant supports a strong maternal in-
ﬂuence. Levels of CML were lower in
newborns than in mothers, a ﬁnding sim-
ilar to that reported for another stable
AGE, pentosidine (20), whereas levels of
more reactive adducts, such as methyl-
glyoxal derivatives were as high in new-
borns as in their mothers.
There was a continued escalation in
sAGElevelsovertheensuingmonthswith
near doubling of sCML levels the ﬁrst 12
months. In addition, infant sMG levels
signiﬁcantly exceeded maternal sMG lev-
els within the same period. These events
were unrelated to blood glucose levels or
to other adverse events that might pro-
mote new AGE formation or restrict their
degradation and/or clearance by the kid-
neys. Instead, the rapid buildup of sAGEs
coincided with the introduction of newly
imported nutrients, which gradually re-
placed breast milk as the primary food
source, and raised daily AGE consump-
tionby5-to7.5-foldwithinthe1styearof
life, in line with previous estimates (of
10-fold) (21).
AGE levels in human breast milk, as
in bovine milk, are well below those in
different commercially produced dairy
products, which can vary by more than
10-fold, depending on the thermal pro-
cessing and packaging procedures (22).
Nutrient-enriched commercial infant for-
mulascontainafargreaterexcessofAGEs
(100- to 400-fold above human milk)
(21,23), a fact that may explain the re-
ported difference in sCML between
breast-fed and formula-fed infants (22).
Thus, widely used AGE-rich formulas, by
raising body AGEs from this young age,
expose infants to an elevated oxidant
stress state, which, although not evident
in the immediate time frame, can become
manifest later in life.
Many of the 6- and 12-month-old in-
fantsofthiscohorthadsMGlevelsseenin
individuals with diabetes or chronic kid-
ney disease (12). It is possible that these
levels decrease, as the infant’s antioxidant
and anti-AGE defenses, including glyox-
alase I and II enzymatic activity or renal
excretory function, attain maturity. How-
ever, given the prominence of glycoxi-
dants in the modern food environment,
sMG levels may increase further with age.
It can be speculated that because AGEs
promote inﬂammation, early build-up of
AGE stores may start undermining innate
defenses from childhood. This is a test-
able hypothesis that may explain the ris-
ing incidence of certain diseases in the
young.
Among the multiple tissues and cells
affected by AGEs, insulin-producing

-cells are also vulnerable to AGE-
induced toxicity in vitro and in mice
(10,16). The standard mouse diet, al-
though normally of low fat content and
Table 2—AGE content in common infant foods and estimated daily AGE intake by infants
between birth and 12 months of age
Infant food (AGE concentration)
Estimated AGE intake (kU/kg/day)
Newborn 6 months 12 months
Milk
Human milk, whole, fresh (52 units/ml) 15 7 0
Cow milk whole, 4% fat (48 units/ml) — — —
Cow milk, powder reconstituted at 10%
(14 units/ml) 0 2 3
Formula
Enfamil (4,861 units/ml) — — —
Solid food
Vegetables/chicken infant meal (2,210 units/ml)* 0 67 108
Vegetables/beef infant meal (2,812 units/ml)* — — —
Vegetables/legume infant meal (1,781 units/ml) — — —
Vegetables/egg infant meal (1,774 units/ml)* — — —
Total estimated AGE intake (kU/kg/day)† 15 76 111‡
*Puree prepared at home with the following ingredients: 15 g chicken, beef, legumes, or egg, 1 medium
size white potato, 2 leaves of spinach or other green vegetables, 1 tablespoon of carrot or squash, and 1
teaspoon of white rice or noodles. All of these ingredients are added to water to a ﬁnal volume of 250 ml
andboiled.Aftertheadditionof1teaspoonofvegetableoil,themixisplacedintheblender.†Theestimated
AGE intake above is representative of most of the infants in this study who went from breast-feeding to the
use of some reconstituted cow milk and eventually solid foods during their 1st year of life. Infants predom-
inantly fed with formulas (e.g., Enfamil) will have a much greater daily AGE intake. ‡Note that adult dietary
AGE intake is 200 kU/kg/day, assuming an average adult weight of 70 kg (6).
Mericq and Associates
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sufﬁcient levels of AGEs to promote di-
abetes, associated with pancreatic islet
inﬂammatory cell inﬁltration and 
-cell
destruction, irrespective of genetic pre-
disposition or type of diabetes (7–10).
This evidence strongly points to the ma-
ternal and the external pro-oxidant envi-
ronmentaspotentialcauses.Also,human
studies indicate that insulin resistance is
in part determined by the in utero envi-
ronment (2) and the maternal eating be-
havior. Thus, exposure to high levels of
AGEs during fetal development and early
childhood could be a decisive event that
turns on the innate immune response to a
proinﬂammatory mode. Once started,
such a course is likely to result in disease,
often diabetes, at a young age (1). This
speculation is herein supported by the re-
lationship between high maternal sAGEs
and higher plasma insulin levels (or
HOMA) in children as young as 1 year
and provides a strong rationale for longer
follow-up studies.
These initial and limited-in-scope
clinical observations are strongly sup-
ported by long-term mouse studies (7).
NOD mice fed a low AGE diet for three
generations had a signiﬁcantly reduced
incidenceoftype1diabetesandamarked
delay in the onset of diabetes with each
successive generation (7). Of note, sAGE
levels in each generation of these mice
were notably lower than in the preceding
progeny,illustratinginthereversethecu-
mulative inﬂuence of maternal and exter-
nalAGEs(7).Arecentstudyshowingthat
a maternal “junk food” diet in pregnancy
and lactation promotes insulin resistance
in rat offspring (24) supports our
postulate.
Among the limitations of this clinical
study were the small sample size, re-
stricted access to infant blood samples,
and lack of a detailed food intake assess-
ment. In addition, our ELISA-based AGE
tests,althoughhighlyvalidated(18),have
been criticized by some authors (25).
Insummary,wepresentevidenceofa
dynamic relationship of maternal and
food-derived AGEs to circulating AGEs
and to select inﬂammatory and metabolic
markers in infants. Taken together, these
data suggest that an elevated maternally
dictatedoxidantAGEburdenininfants,if
combined with AGE-rich infant foods,
may negatively precondition infants to
high oxidant stress and weaken innate re-
sistance to or raise incidence of disease,
such as diabetes in young individuals.
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